148 related articles for article (PubMed ID: 35909258)
1. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
Chung SJ; Byeon SJ; Choi JH
J Korean Med Sci; 2022 Apr; 37(16):e128. PubMed ID: 35470602
[TBL] [Abstract][Full Text] [Related]
3. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
[TBL] [Abstract][Full Text] [Related]
5. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.
Mouton JP; Njuguna C; Kramer N; Stewart A; Mehta U; Blockman M; Fortuin-De Smidt M; De Waal R; Parrish AG; Wilson DPK; Igumbor EU; Aynalem G; Dheda M; Maartens G; Cohen K
Medicine (Baltimore); 2016 May; 95(19):e3437. PubMed ID: 27175644
[TBL] [Abstract][Full Text] [Related]
6. Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco.
El Hamdouni M; Ahid S; Bourkadi JE; Benamor J; Hassar M; Cherrah Y
Infection; 2020 Feb; 48(1):43-50. PubMed ID: 31165445
[TBL] [Abstract][Full Text] [Related]
7. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
[TBL] [Abstract][Full Text] [Related]
9. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions in tuberculosis and management.
Prasad R; Singh A; Gupta N
Indian J Tuberc; 2019 Oct; 66(4):520-532. PubMed ID: 31813444
[TBL] [Abstract][Full Text] [Related]
12. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
[TBL] [Abstract][Full Text] [Related]
13. Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
Sant Anna FM; Araújo-Pereira M; Schmaltz CAS; Arriaga MB; Andrade BB; Rolla VC
PLoS One; 2023; 18(2):e0269765. PubMed ID: 36749743
[TBL] [Abstract][Full Text] [Related]
14. High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors.
Nanyonga SM; Kitutu FE; Kalyango J; Frank M; Kiguba R
J Acquir Immune Defic Syndr; 2022 Feb; 89(2):215-221. PubMed ID: 34693930
[TBL] [Abstract][Full Text] [Related]
15. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
P V K; Palaian S; Ojha P; P R S
Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India.
Rupani MP; Dave JD; Parmar VB; Singh MP; Parikh KD
Natl Med J India; 2020; 33(1):10-14. PubMed ID: 33565479
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China.
Han XQ; Pang Y; Ma Y; Liu YH; Guo R; Shu W; Huang XR; Ge QP; DU J; Gao WW
Biomed Environ Sci; 2017 Feb; 30(2):139-142. PubMed ID: 28292352
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Adverse Reactions Induced by Anti-Tuberculosis Drugs in Hospital Pulau Pinang.
Fei CM; Zainal H; Ali IAH
Malays J Med Sci; 2018 Sep; 25(5):103-114. PubMed ID: 30914867
[TBL] [Abstract][Full Text] [Related]
19. Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature.
Kargar M; Mansouri A; Hadjibabaie M; Javadi M; Radfar M; Gholami K
Expert Opin Drug Saf; 2014 Jul; 13(7):875-91. PubMed ID: 24935479
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions associated with first-line anti-tuberculosis drug regimens.
Marra F; Marra CA; Bruchet N; Richardson K; Moadebi S; Elwood RK; Fitzgerald JM
Int J Tuberc Lung Dis; 2007 Aug; 11(8):868-75. PubMed ID: 17705952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
